Applications of Immunocytochemistry to Clinical Cytology

References

• Old LJ. Cancer immunology: the search for specificity. Cancer Res 1981; 41: 361–375
   PubMed Web of Science ®Google Scholar
• Kohler M, Milstein C. Continuous Cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–497
   PubMed Web of Science ®Google Scholar
• Nadji M. The potential value of immunoperoxidase techniques in diagnostic cytology. Acta Cytol 1980; 24: 442–447
   PubMed Web of Science ®Google Scholar
• To A, Coleman DV, Dearnaley DP, et al. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol 1981; 34: 1326–1332
   PubMed Web of Science ®Google Scholar
• To A, Deamaley DP, Ormerod G, et al. Epithelial membrane antigen: its use in the cytodiagnosis of malignancy in serous effusions. Am J Clin Pathol 1982; 77: 214–219
   Google Scholar
• Orell SR, Dowling KD. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions. Acta Cytol 1983; 27: 625–629
   PubMed Web of Science ®Google Scholar
• Sehested M, Ralkjaer E, Rasmussen J. lmmunoperoxidase demonstration of carcino-embryonic antigen in pleural and peritoneal effusions. Acta Cytol 1983; 27: 124–127
   PubMed Web of Science ®Google Scholar
• Droese M, Altmannsbergr M, Kehl A, et al. Ultrasound-guided percutaneous fine needle aspiration biopsy of abdominal and retroperitoneal masses. Acta Cytol 1984; 28: 368–384
   PubMed Web of Science ®Google Scholar
• Ramaekers F, Haag D, Jap P, et al. Immunochemical demonstration of keratin and vimentin in cytologic aspirates. Acta Cytol 1984; 28: 385–392
   PubMed Web of Science ®Google Scholar
• Walts AE, Said JW, Banks-Schlegel S. Keratin and carcinoembryonic antigen in exfoliated mesothelial and malignant cells: an immunoperoxidase study. Am J Clin Pathol 1983; 80: 671–676
   PubMed Web of Science ®Google Scholar
• Walts AE, Said JW, Shintaku IP, et al. Keratins of different molecular weight in exfoliated mesothelial and ademcarcinoma cells—an aid to cell identification. Am J Clin Pathol 1984; 81: 442–446
   PubMed Web of Science ®Google Scholar
• Kyrkou KA, Latridis SG, Athanissiadou PP, et al. Detection of benign or malignant origin of ascites with combined indirect immunoperoxidase assays of carcinoembryonic antigen and lysozyme. Acta Cytol 1985; 2957–62
   Web of Science ®Google Scholar
• Levitt S, Cheng L, DuPuis MH, et al. Fine needle aspiration diagnosis of malignant lymphoma with confirmation by immunoperoxidase staining. Acta Cytol 1985; 29: 895–902
   PubMed Web of Science ®Google Scholar
• Osamura RY, Watanabe K, Akatsuka Y. Peroxidase-labeled antibody staining for carcinoembryonic antigen of cytologic specimens for light and electron microscopy. Acta Cytol 1985; 29: 254–256
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Yasumura K, Murakoshi M, et al. Application of immuno-electron microscopy to the cytologic study of benign and malignant mammary lesions. Acta Cytol 1985; 29: 257–261
   PubMed Web of Science ®Google Scholar
• Banner BF, Warren WH, Could VE. Cytomorphology and marker expression of malignant neuroendocrine cells in pleural effusions. Acta Cytol 1986; 30: 99–104
   PubMed Web of Science ®Google Scholar
• Chess Q, Hajdu SI. The role of immunoperoxidase staining in diagnostic cytology. Acta Cytol 1986; 30: 1–7
   PubMed Web of Science ®Google Scholar
• Pinto MM. An immunoperoxidase study of S-100 protein in neoplastic cells in serous effusions. Acta Cytd 1986; 30: 240–244
   PubMed Web of Science ®Google Scholar
• Epenetos AA, Canti G, Taylor-Papadimitriou J, et al. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions?. The Lancet Nov. 1982; 6: 1004–1006
   Google Scholar
• Woods JC, Spriggs AI, Harris H, et al. A new marker for human cancer cells. III. Immunocytochemical detection of malignant cells in serous fluids with the CAI antibody?. The Lancet Sept. 1982; 4: 512–515
   Google Scholar
• Ghosh AK, Mason DY, Spriggs AI. Immunocytochemical staining with monoclonal antibodies in cytologically “negative” serous effusions from patients with malignant disease. J Clin Pathol 1983; 36: 1150–1153
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Spriggs AI, Taylor-Papadimitrious J, et al. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. J Clin Pathol 1983; 36: 1154–1164
   PubMed Web of Science ®Google Scholar
• Collins VP. Monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors. Acta Cytol 1984; 28: 401–406
   PubMed Web of Science ®Google Scholar
• Yam LT, Winkler CF. Immunocytochemical diagnosis of oat-cell carcinoma in pleural effusion. Acta Cytol 1984; 28: 425–429
   PubMed Web of Science ®Google Scholar
• Yam LT, Lin DG, Janckila AJ, et al. Immunocytochemical diagnosis of lymphoma in serous effusions. Acta Cytol 1985; 29: 833–841
   PubMed Web of Science ®Google Scholar
• Menard S, Rilke F, Torre GD, et al. Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies. Am J Clin Pathol 1985; 83: 571–576
   PubMed Web of Science ®Google Scholar
• Domagala W, Lubinski J, Weber K, et al. Intermediate filament typing of tumor cells in fine needle aspirates by means of monoclonal antibodies. Acta Cytol 1986; 30: 214–224
   PubMed Web of Science ®Google Scholar
• Domagala W, Weber K, Osborn M. Differential diagnosis of lymph node aspirates by intermediate filament typing of tumor cells. Acta Cytol 1986; 30: 225–234
   PubMed Web of Science ®Google Scholar
• Hilborne LH, Cheng L, Nieberg RK, et al. Evaluation of an antibody to human milk fat globule antigen in the detection of metastatic carcinoma in pleura, pericardial and peritoneal fluids. Acta Cytol 1986; 30: 245–250
   PubMed Web of Science ®Google Scholar
• Colcher H, Horan Hand P, Nuti M, et al. A spectrum of monoclonal antibodies reactive with mammary tumor cells. Proc Natl Acad Sci (USA) 1981; 78: 3199–3203
   PubMed Web of Science ®Google Scholar
• Colcher D, Horan Hand P, Nuti M, et al. Differential binding to human mammary and nonmammary tumors of monoclonal antibodies reactive with carcinoembryonic antigen. Cancer Invest 1983; 1: 127–138
   PubMed Web of Science ®Google Scholar
• Colcher D, Horan Hand P, Wunderlich D, . Monoclonal antibodies to human mammary carcinoma Associated antigens and their potential uses for diagnosis, prognosis, and treatment. Immuno-diagnostics Laboratory and Research Methods in Biological Medicine, MR. Aloisi, J. Hyun, et al. Alan R. Liss Inc., New York 1983; 215–258
   Google Scholar
• Colcher D, Zalutsky M, Kaplan W, et al. Radiolocalizaiton of human mammary tumors in athymic mice. Cancer Res 1983; 43: 735–742
   Web of Science ®Google Scholar
• Kufe D, Inghirami G, Abe M, et al. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984; 3: 223–232
   PubMed Web of Science ®Google Scholar
• Nuti M, Teramoto YA, Mariani-Costantini R, et al. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in hum mammary carcinoma cell populations. Int J Cancer 1982; 29: 539–545
   PubMed Web of Science ®Google Scholar
• Stramignoni D, Bowen R, Atkinson BF, et al. Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Int J Cancer 1983; 31: 543–552
   PubMed Web of Science ®Google Scholar
• Horan Hand P, Colcher D, Salomon D, et al. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor associated glycoprotein. Cancer Res 1985; 45: 833–840
   PubMed Web of Science ®Google Scholar
• Johnson VG, Schlom J, Paterson AJ, et al. Analysis of human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 1986; 46: 850–857
   PubMed Web of Science ®Google Scholar
• Lottich SC, Johnston WW, Szpak CA, et al. Correlation of the expression of a tumor-Associated antigen (TAG-72) in primary and metastatic breast carcinoma lesions. Breast Cancer Res Treat 1985; 6: 49–55
   PubMed Web of Science ®Google Scholar
• Szpak CA, Johnston WW, Roggli V, et al. The significance of monoclonal antibody (B72.3) in the diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung. Am J Pathol 1986; 122: 252–260
   PubMed Web of Science ®Google Scholar
• Thor A, Gorstem F, Ohuchi N, et al. MAb 872.3 defines TAG—72 in ovarian carcinomas. J Natl Cancer Inst 1986; 76: 995–1006
   PubMed Web of Science ®Google Scholar
• Thor A, Ohuchi N, Szpak CA, et al. MAb B72.3 defines the distribution of the oncofetal antigen TAG-72. Cancer Res 1986; 46: 3118–3124
   PubMed Web of Science ®Google Scholar
• Friedman EL, Hayes DF, Kufe DW. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas. Cancer Res 1986; 46: 5189–5194
   PubMed Web of Science ®Google Scholar
• Szpak CA, Johnston WW, Lottich SC, et al. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, Bl.1, and B6.2) with cells in human malignant and benign effusions. Acta Cytol 1984; 28: 356–367
   PubMed Web of Science ®Google Scholar
• Johnston WW, Szpak CA, Lottich SC, et al. An adenocarcinoma Associated determinant in human effusions: Use of a monoclonal antibody as an immunocytochemical adjuvant to diagnoses. Cancer Res 1985; 45: 1894–1900
   PubMed Web of Science ®Google Scholar
• Martin SE, Moshiri S, Thor A, et al. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3. Am J Clin Pathol 1986; 86: 10–18
   PubMed Web of Science ®Google Scholar
• Johnston WW, Szpak CA, Lottich SC, et al. Use of a monoclonal antibody (B72.3) as a novel immunocytochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens. Human Pathol 1986; 17: 501–513
   PubMed Web of Science ®Google Scholar
• Johnston WW, Szpak CA, Thor A, et al. Phenotypic characterization of lung cancers in tine needle aspiration biopsies using monoclonal antibody B72.3. Cancer Res 1986; 46: 6462–6470
   PubMed Web of Science ®Google Scholar
• Johnston WW. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3: The George N. Papanicolaou Award Lecture. Acta Cycol, in press
   Google Scholar
• Hsu SM, Raine L, Fanger H. Use of Avidin-Biotin-Peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PA) procedures. J Histo-chem Cytochem 1981; 29: 577–580
   PubMed Web of Science ®Google Scholar
• Johnston WW. Perspectives in cytological diagnoses. The Pleura in Health and Disease, J. Chretien, J. Bignon, A. Hirsch. Marcel Dekker, New York 1984; 761–785
   Google Scholar
• Johnston WW. The malignant pleural effusion: clinical implications of cytopathological diagnoses of 464 consecutive patients. Cancer 1985; 56: 905–909
   PubMed Web of Science ®Google Scholar
• Johnston WW. Percutaneous fine needle aspiration biopsy of the lung. A study of 1, 015 patients. Acta Cytol 1984; 28: 218–224
   PubMed Web of Science ®Google Scholar
• Ashton PR, Hollingsworth A, Johnston WW. The cytopathology of metastatic breast cancer. Acta Cytol 1975; 19: l–6
   Web of Science ®Google Scholar
• Schlom J, Weeks MO. Potential clinical utility of monoclonal antibodies in the management of human carcinomas. Important Advances in Oncology 1985, VT. Devita, S. Hellman, SA. Rosenberg, JB. Lippincott, Philadelphia, Toronto 1985; 170–192
   Google Scholar
• Lundy J, Lozowki M, Mushriki Y. Monoclonal antibody B72.3 as a diagnostic adjunct in fine needle aspirates of breast masses. Ann Surg, in press
   Web of Science ®Google Scholar
• Nuti M, Mottolese M, Viora M, et al. Use of monoclonal antibodies to human breast tumor Associated antigens in fine needle aspirate cytology. Int J Cancer 1986; 37: 493–498
   PubMed Web of Science ®Google Scholar
• Perry MD, Seigler FH, Johnston WW. Diagnosis of metastatic malignant melanoma by fine needle aspiration biopsy. J Natl Cancer Inst 1986; 77: 1013–1021
   PubMed Web of Science ®Google Scholar
• Johnston WW, Borowia MJ, Stuhlmiller GM, et al. Expression of a melanoma tumor Associated antigen as demonstrated by a monoclonal antibody (D6.1) in cytopathologic prepartions of human tumor cells from effusions and needle aspirates. Anal Quant Cytol 1985; 7: 72–80
   PubMedGoogle Scholar
• Thor A, Viglione UT, Muraro R, et al. Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues. Int J Gynecol Pathol, in press
   Web of Science ®Google Scholar
• Kobayashi TK, Yamaki T, Yoshino E, et al. Immunocytcchemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer. Acta Cytol 1984; 28: 430–434
   PubMed Web of Science ®Google Scholar
• Broghamer WL, Jr, Richardson ME, Faurest WS, et al. Prostatic acid phosphatase immunoperoxidase staining cytologically positive effusions associated with adenocarcinoma of the prostate and neoplasms of undetermined origin. Acta Cytol 1985; 29: 274–278
   PubMed Web of Science ®Google Scholar
• Bartziota EV. Fine needle aspiration cytology of prostatic adenmarcinoma metastatic to the lung confirmed by the immunoperoxidase technique. Acta Cytol 1986; 30: 497–500
   PubMed Web of Science ®Google Scholar
• Vick WW, Bigner SH, Wikstrand CJ, et al. The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous system. Acta Cytol, in press
   Web of Science ®Google Scholar
• Trojanowski JQ, Atkinson B, Lee VMY. An immunocytcchemical study of normal and abnormal human cerebrospinal fluid with monoclonal antibodies to glial fibrillary acidic protein. Acta Cytol 1986; 30: 1235–239
   Web of Science ®Google Scholar